These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 37713098)

  • 1. Enrollment Forecast for Clinical Trials at the Planning Phase with Study-Level Historical Data.
    Yu M; Zhong S; Xing Y; Wang L
    Ther Innov Regul Sci; 2024 Jan; 58(1):42-52. PubMed ID: 37713098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enrollment forecast for clinical trials at the portfolio planning phase based on site-level historical data.
    Zhong S; Xing Y; Yu M; Wang L
    Pharm Stat; 2024; 23(2):151-167. PubMed ID: 37871925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real time monitoring and prediction of time to endpoint maturation in clinical trials.
    Wang L; Liu Y; Chen X; Pulkstenis E
    Stat Med; 2022 Aug; 41(18):3596-3611. PubMed ID: 35587584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical modeling and prediction of clinical trial recruitment.
    Lan Y; Tang G; Heitjan DF
    Stat Med; 2019 Mar; 38(6):945-955. PubMed ID: 30411375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing a phase-III time-to-event clinical trial using a modified sample size formula and Poisson-Gamma model for subject accrual that accounts for the lag in site initiation using the PERT distribution.
    Shipes VB; Meinzer C; Wolf BJ; Li H; Carpenter MJ; Kamel H; Martin RH
    Stat Med; 2023 Dec; 42(30):5694-5707. PubMed ID: 37926516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A simple and robust model for enrollment projection in clinical trials.
    Zhang X; Huang B
    Contemp Clin Trials; 2022 Dec; 123():106999. PubMed ID: 36371001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A time-dependent Poisson-Gamma model for recruitment forecasting in multicenter studies.
    Turchetta A; Savy N; Stephens DA; Moodie EEM; Klein MB
    Stat Med; 2023 Oct; 42(23):4193-4206. PubMed ID: 37491664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling and prediction of subject accrual and event times in clinical trials: a systematic review.
    Zhang X; Long Q
    Clin Trials; 2012 Dec; 9(6):681-8. PubMed ID: 22674642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bayesian accrual modeling and prediction in multicenter clinical trials with varying center activation times.
    Liu J; Wick J; Jiang Y; Mayo M; Gajewski B
    Pharm Stat; 2020 Sep; 19(5):692-709. PubMed ID: 32319194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accrual Prediction Program: A web-based clinical trials tool for monitoring and predicting accrual for early-phase cancer studies.
    Liu J; Wick JA; Mudaranthakam DP; Jiang Y; Mayo MS; Gajewski BJ
    Clin Trials; 2019 Dec; 16(6):657-664. PubMed ID: 31451012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bayesian model selection techniques as decision support for shaping a statistical analysis plan of a clinical trial: an example from a vertigo phase III study with longitudinal count data as primary endpoint.
    Adrion C; Mansmann U
    BMC Med Res Methodol; 2012 Sep; 12():137. PubMed ID: 22962944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cross-sectional study of participant recruitment rates in published phase III influenza therapeutic randomized controlled trials conducted in the clinical setting.
    Rothman RE; Niforatos JD; Youbi M; Polydefkis N; Hergenroeder A; Ako MC; Lobner K; Shaw-Saliba K; Hsieh YH
    Am J Emerg Med; 2022 Nov; 61():184-191. PubMed ID: 36174486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using Poisson-gamma model to evaluate the duration of recruitment process when historical trials are available.
    Minois N; Lauwers-Cances V; Savy S; Attal M; Andrieu S; Anisimov V; Savy N
    Stat Med; 2017 Oct; 36(23):3605-3620. PubMed ID: 28608361
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stochastic modeling and prediction for accrual in clinical trials.
    Zhang X; Long Q
    Stat Med; 2010 Mar; 29(6):649-58. PubMed ID: 20082363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of clinical trial enrollment rates.
    Bieganek C; Aliferis C; Ma S
    PLoS One; 2022; 17(2):e0263193. PubMed ID: 35202402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Probabilistic seasonal dengue forecasting in Vietnam: A modelling study using superensembles.
    Colón-González FJ; Soares Bastos L; Hofmann B; Hopkin A; Harpham Q; Crocker T; Amato R; Ferrario I; Moschini F; James S; Malde S; Ainscoe E; Sinh Nam V; Quang Tan D; Duc Khoa N; Harrison M; Tsarouchi G; Lumbroso D; Brady OJ; Lowe R
    PLoS Med; 2021 Mar; 18(3):e1003542. PubMed ID: 33661904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Forecasting daily patient volumes in the emergency department.
    Jones SS; Thomas A; Evans RS; Welch SJ; Haug PJ; Snow GL
    Acad Emerg Med; 2008 Feb; 15(2):159-70. PubMed ID: 18275446
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.